Метаболічні порушення у хворих на гіпертонічну хворобу як науковий напрямок кафедри сімейної медицини

S. V. Biletskyi, O. A. Petrynych, T. V. Kazantseva

Анотація


У роботі узагальнюються результати наукових досліджень кафедри сімейної медицини щодо вивчення метаболічних порушень у хворих на гіпертонічну хворобу та їх зміни під впливом патогенетично обґрунтованого лікування.


Ключові слова


кафедра; науковий напрямок; гіпертонічна хвороба; метаболічні порушення

Повний текст:

PDF

Посилання


Amosova KM, Yaremenko OB, Kovhanich TO. Efficacy and tolerability of the drug lercanidipine in patients with mild to moderate hypertension. Ukrains'kyi kardiolohichnyi zhurnal. 2004;3:42-7. (in Ukrainian).

Bilets'kyi SV, Petrynych OA, Kazantseva TV. Effect of pioglitazone on proteolysis and hemostasis in patients with hypertension combined with diabetes of the second type. Bukovyns'kyi medychnyi visnyk. 2013;17(1):19-2. (in Ukrainian).

Bilets'kyi SV, Kazantseva TV, Zorii IA. Clinical and biochemical markers of metabolic syndrome, hypertension in adults and children. Bukovyns'kyi medychnyi visnyk. 2008;12(1):75-1. (in Ukrainian).

Bilets'kyi SV, Petrynych OA, Kazantseva TV, Pavlovych LB. Hemodynamic and metabolic disorders in patients with hypertension combined with diabetes mellitus type 2, correction possibilities. Chernivtsi: Bukovyns'kyi derzhavnyi medychnyi universytet; 2012. 294 p. (in Ukrainian).

Biletskiy SV, Gozhenko AI, Bobylev AV. Hypoxic-hypercapnic training in cardiology. Chernivtsi: BDMU; 2007. 148 p. (in Russian).

Efimov AS, Sokolova LK, Rybchenko YuB. Diabetes and heart. Available at: http://www.m-l.com.ua/?aid=495 (30.07.2009).

Health care morbidity and Ukraine in 2006. Statistical Bulletin. State Statistics Committee of Ukraine. Kyiv; 2007. 45 p. (in Ukrainian).

Zorii IA, Biletskiy SV. Differential diagnosis of hypothalamic and metabolic syndrome in children and adolescents. Klinichna ta eksperymental'na patolohiia. 2008;7(1):46-0. (in Ukrainian).

Zorii IA, Biletskiy SV, Shevchuk NM. Clinical and biochemical markers of metabolic syndrome in children and adolescents. Bukovyns'kyi medychnyi visnyk. 2007;11(2):40-4. (in Ukrainian).

Kazantseva TV, Biletskiy SV. Imidazoline receptor agonist - fiziotenz therapy in patients with hypertension and type 2 diabetes. Bukovyns'kyi medychnyi visnyk. 2006;10(2):26-9. (in Ukrainian).

Kazantseva TV, Biletskiy SV. The use of hypoxic-hiperkapnichnyh exercise by breathing through an additional "dead" space in the treatment of hypertensive patients with concomitant diabetes mellitus type 2. Bukovyns'kyi medychnyi visnyk. 2007;11(1):26-9. (in Ukrainian).

Kolomoiets' MIu, Taschuk VK. Chernivtsi school therapists. Internal Medicine. 2007. Available at: http:// www.mif-ua.com/archive/article/2859 (in Ukrainian)

Kosygina AV, Vasyukova OV. New in the pathogenesis of obesity: adipokines - hormones adipose tissue. Problemy endokrinologii. 2009;55(1):44-9. (in Russian).

Petrynych OA, Bilets'kyi SV, Mel'nychuk LV. Features of metabolic disorders in hypertensive patients and in combination with diabetes type 2: the relationship with insulin resistance. Bukovyns'kyi medychnyi visnyk. 2009;13(3):61-5. (in Ukrainian).

Pan'kiv VI. Insulin resistance as a key pathophysiologic mechanism of the metabolic syndrome. Praktychna anhiolohiia. 2012;5-6:24-8. (in Ukrainian).

Petrynych OA. Effect of pioglitazone on metabolic parameters in patients with hypertension combined with diabetes of the second type. Klinichna ta eksperymental'na patolohiia. 2010;9(4):74-8. (in Ukrainian).

Petrynych OA. The use of S-amlodipine and its combination with lisinopril in hypertensive patients: impact on hemodynamic and metabolic parameters. Aktual'ni problemy suchasnoi medytsyny. Visnyk Ukrains'koi medychnoi stomatolohichnoi akademii. 2010;10(3):219-4. (in Ukrainian).

Petrynych OA. Lipid peroxidation and antioxidant protection in hypertensive patients and in combination with diabetes mellitus type 2. Klinichna ta eksperymental'na patolohiia. 2009;VIII(3):74-8. (in Ukrainian).

Petrynych OA, Bilets'kyi SV. State of hemostasis and proteolysis in hypertensive patients and with concomitant diabetes mellitus type 2 diabetes: relationship with metabolic disorders. Halyts'kyi likars'kyi visnyk. 2009;16(4):66-9. (in Ukrainian).

Kovalenko VM. “ed.”. The health of the people of Ukraine due to illness circulatory system and possible ways of its improvement. Kyiv; 2004. 124 p. (in Ukrainian).

Chekman IS, Datsiuk NO. The role of lipid peroxidation in the pathogenesis of hypertension. Sertse i sudyny. 2008;4:110-5. (in Ukrainian).

Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Amer. J. Physiol. Regul. Integr. Comp. Physiol. 2004;286:R803-3.

Ding Y, Li YM, Zimmerman M. Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits. Сardiovasc. Res. 2009;81:678-5.

Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia. 2003;46(12):1594-3.

Hotamisligil GS. Inflammatory pathways and insulin action. Int. J. Obes. Relat. Metab. Disord. 2003;27:S53-5.

Levy D, Garrison RJ, Savage DD. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New Engl. J. Med . 1990;322:1561-6.


Пристатейна бібліографія ГОСТ






DOI: https://doi.org/10.24061/101900

Посилання

  • Поки немає зовнішніх посилань.


Copyright (c) 2017 S. V. Biletskyi, O. A. Petrynych, T. V. Kazantseva

Технічний редактор журналу, к.мед.н. М. Степанченко, 2015-2017